Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol

被引:0
作者
Jennifer E. Lambert
Jill A. Parnell
Bertus Eksteen
Maitreyi Raman
Marc R. Bomhof
Kevin P. Rioux
Karen L. Madsen
Raylene A. Reimer
机构
[1] University of Calgary,Faculty of Kinesiology
[2] Mount Royal University,Health and Physical Education
[3] University of Calgary,Snyder Institute for Chronic Diseases, Health Research and Innovation Center
[4] University of Calgary,Division of Gastroenterology and Hepatology, Department of Medicine
[5] University of Calgary,Department of Microbiology and Infectious Diseases
[6] University of Alberta,Division of Gastroenterology, Centre of Excellence for Gastrointestinal Inflammation and Immunity Research, 7–142 Katz Group–Rexall Centre
[7] Department of Biochemistry & Molecular Biology,undefined
[8] Cumming School of Medicine,undefined
来源
BMC Gastroenterology | / 15卷
关键词
Prebiotic fiber; Gut microbiota; Fatty liver; Weight loss; Fibrosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 503 条
[1]  
Yilmaz Y(2014)Obesity-associated nonalcoholic fatty liver disease Clin Liver Dis 18 19-31
[2]  
Younossi ZM(2014)The role of diet and nutritional intervention for the management of patients with NAFLD Clin Liver Dis 18 91-112
[3]  
Barrera F(2011)Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 124-131
[4]  
George J(2004)Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 1387-1395
[5]  
Williams CD(2005)Insulin resistance: a metabolic pathway to chronic liver disease Hepatology 42 987-1000
[6]  
Stengel J(2003)Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 76-79
[7]  
Asike MI(1998)Steatohepatitis: A tale of two “hits”? Gastroenterology 114 842-845
[8]  
Torres DM(2013)Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD) Nutrients 5 4093-4114
[9]  
Shaw J(2014)Obesity and NAFLD: The role of bacteria and microbiota Clin Liver Dis 18 59-71
[10]  
Contreras M(2013)Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis Clin Mol Hepatol 19 210-215